Volume | 778,211 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 3.57 | Mínimo Máximo |
|||||
Minimo del Dia | 3.302 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
ADC Therapeutics SA | ADCT | NYSE | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.41 | 3.302 | 3.57 | 3.43 | 3.44 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
6,102 | 778,211 | US$ 3.44 | US$ 2,678,396 | - | 0.359908 - 6.04 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:33:17 | formt | 800 | US$ 3.31 | USD |
Información Financiera ADC Therapeutics SA ADCT
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
281.43M | 82.53M | - | 69.56M | -234.53M | -2.84 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre ADC Therapeutics SA ADCT
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
30/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in the Jefferies Global.. |
15/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in the H.C. Wainwright 2nd.. |
14/5/2024 | 11:32 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 15:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
09/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in 2024 RBC Capital Markets.. |
08/5/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 15:06 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
07/5/2024 | 15:02 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
06/5/2024 | 06:30 | GlobeNewswire Inc. | ADC Therapeutics Announces $105 Million Underwritten.. |
06/5/2024 | 05:51 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
06/5/2024 | 05:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/5/2024 | 05:29 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos ADCT
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.61 | 3.87 | 3.27 | 3.49 | 500,223 | -0.30 | -8.31% |
1 Month | 4.96 | 5.17 | 3.27 | 4.14 | 695,525 | -1.65 | -33.27% |
3 Months | 5.00 | 5.38 | 3.23 | 4.37 | 561,975 | -1.69 | -33.80% |
6 Months | 0.8249 | 6.04 | 0.8094 | 3.31 | 765,091 | 2.49 | 301.26% |
1 Year | 2.28 | 6.04 | 0.359908 | 2.66 | 571,336 | 1.03 | 45.18% |
3 Years | 21.65 | 32.00 | 0.359908 | 6.09 | 432,402 | -18.34 | -84.71% |
5 Years | 30.00 | 56.5899 | 0.359908 | 10.65 | 388,834 | -26.69 | -88.97% |